CELL CYCLE DEPENDENCE OF ANTICANCER DRUG CYTOTOXICITY

抗癌药物细胞毒性的细胞周期依赖性

基本信息

  • 批准号:
    3166089
  • 负责人:
  • 金额:
    $ 11.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1978
  • 资助国家:
    美国
  • 起止时间:
    1978-04-01 至 1986-03-31
  • 项目状态:
    已结题

项目摘要

The objective of this research is to determine the role of DNA damage and repair in the cell cycle phase-dependent cytotoxicity of anticancer drugs. These studies will take advantage of new technology developed in the areas of tumor cell synchronization (centrifugal elutriation) and detection of DNA damage in tissues (alkaline elution) thus allowing investigations to be conducted both in vitro and in vivo. While it is generally thought that many of the anticancer drugs in current use, including the alkylating agents, antitutmor antibiotics, and DNA intercalating drugs, have DNA as their principal molecular target in the cell, it will be necessary to test this hypothesis for many of these agents. We also propose to determine whether the DNA damage made by such drugs is susceptible to cellular DNA mechanisms and whether the action of repair contributes to cell survival. This aspect of the research will take advantage of the recently available repair-deficient mutants isolated from cultured mammalian cells. Finally, we intend to try to relate the findings from the basic studies above to the situation in an animal being treated with the antitumor agent by measuring the pharmacokinetics of the drug in the various animal's normal and tumor tissues in terms of the DNA damage produced and repair of that damage as a function of time following treatment. This information should greatly add to our understanding of the basic cellular and molecular mechanisms responsible for various aspects of cancer chemotherapy.
这项研究的目的是确定DNA损伤和修复的作用

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROSE Y TSENG其他文献

ROSE Y TSENG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROSE Y TSENG', 18)}}的其他基金

Enhancement of Research Infrastructure at UH Hilo
加强夏威夷大学希洛分校的研究基础设施
  • 批准号:
    6954176
  • 财政年份:
    2004
  • 资助金额:
    $ 11.53万
  • 项目类别:
Enhancement of Research Infrastructure at UH Hilo
加强夏威夷大学希洛分校的研究基础设施
  • 批准号:
    7127202
  • 财政年份:
    2004
  • 资助金额:
    $ 11.53万
  • 项目类别:
Enhancement of Research Infrastructure at UH Hilo
加强夏威夷大学希洛分校的研究基础设施
  • 批准号:
    7294236
  • 财政年份:
    2004
  • 资助金额:
    $ 11.53万
  • 项目类别:
Enhancement of Research Infrastructure at UH Hilo
加强夏威夷大学希洛分校的研究基础设施
  • 批准号:
    7495637
  • 财政年份:
    2004
  • 资助金额:
    $ 11.53万
  • 项目类别:
Enhancement of Research Infrastructure at UH Hilo
加强夏威夷大学希洛分校的研究基础设施
  • 批准号:
    6887639
  • 财政年份:
    2004
  • 资助金额:
    $ 11.53万
  • 项目类别:

相似海外基金

Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
  • 批准号:
    10374792
  • 财政年份:
    2021
  • 资助金额:
    $ 11.53万
  • 项目类别:
Elucidation and prevention of the mechanism of hepatic sinusoidal obstruction syndrome (SOS) induced by DNA alkylating agents
DNA烷化剂诱发肝窦阻塞综合征(SOS)机制的阐明和预防
  • 批准号:
    21K15255
  • 财政年份:
    2021
  • 资助金额:
    $ 11.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
  • 批准号:
    10570900
  • 财政年份:
    2021
  • 资助金额:
    $ 11.53万
  • 项目类别:
Development of individualized therapy by elucidation of molecular mechanisms for hypermutation phenotype induced by treatment with alkylating agents in glioma
通过阐明神经胶质瘤中烷化剂治疗诱导的超突变表型的分子机制来开发个体化治疗
  • 批准号:
    18K09004
  • 财政年份:
    2018
  • 资助金额:
    $ 11.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Reversing intrinsic cancer cell resistance to alkylating agents by histone deacetylase inhibition
通过组蛋白脱乙酰酶抑制逆转癌细胞对烷化剂的内在耐药性
  • 批准号:
    214657440
  • 财政年份:
    2012
  • 资助金额:
    $ 11.53万
  • 项目类别:
    Research Grants
Rerouting alkylating agents to the mitochondria for cancer therapy
将烷化剂重新路由至线粒体用于癌症治疗
  • 批准号:
    247842
  • 财政年份:
    2011
  • 资助金额:
    $ 11.53万
  • 项目类别:
    Studentship Programs
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8105413
  • 财政年份:
    2010
  • 资助金额:
    $ 11.53万
  • 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8271313
  • 财政年份:
    2010
  • 资助金额:
    $ 11.53万
  • 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8730259
  • 财政年份:
    2010
  • 资助金额:
    $ 11.53万
  • 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8676463
  • 财政年份:
    2010
  • 资助金额:
    $ 11.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了